About Firm News
In the News
Lisa Dwyer discusses the FDA’s final rule that gives the agency broad authority over lab-developed tests by classifying them as medical devices
April 29, 2024
| Law360, BioWorld MedTech, Medtech Insight, Pink Sheet, BioPharma Dive, Inside Health Policy and STAT News

Go to the Law360 article

Go to the BioWorld MedTech article

Go to the Medtech Insight article

Go to the Pink Sheet article

Go to the BioPharma Dive article

Go to the Inside Health Policy article

Go to the STAT News article

Related Capabilities
Special Matters & Government Investigations FDA & Life Sciences
Explore King & Spalding
a blue and green background
Capabilities
Special Matters & Government Investigations
Learn More
a blue and green background
Capabilities
FDA & Life Sciences
Learn More